TD Cowen Maintains Buy on Thermo Fisher Scientific, Raises Price Target to $760
10/13/2026
Impact: 75
Healthcare
TD Cowen analyst Dan Brennan has maintained a Buy rating on Thermo Fisher Scientific (NYSE: TMO) and increased the price target from $675 to $760. This adjustment reflects a positive outlook for the company in the market.
AI summary, not financial advice
Share: